Intersect ENT Inc.

NASDAQ: XENT · Real-Time Price · USD
28.24
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Intersect ENT Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
106.75M
Cost of Revenue
30.01M
Gross Profit
76.74M
Operating Income
-154.89M
Interest Income
n/a
Pretax Income
-161.32M
Net Income
-159.63M
Selling & General & Admin
122.07M
Research & Development
27.94M
Other Expenses
n/a
Operating Expenses
150.01M
Interest Expense
6.44M
Selling & Marketing Expenses
n/a
Cost & Expenses
180.02M
Income Tax Expense
-1.69M
Shares Outstanding (Basic)
33.27M
Shares Outstanding (Diluted)
33.27M
EPS (Basic)
-4.8
EPS (Diluted)
-4.8
EBITDA
-150.08M
EBIT
-154.89M
Depreciation & Amortization
4.81M